TSRI scientist and partners receive $7.2 million grant to create new RNA-based treatments for ALS

TSRI scientist and partners receive $7.2 million grant to create new RNA-based treatments for ALS:

Dementia Big
Professor Matthew Disney of the Department of Chemistry on the Florida campus of The Scripps Research Institute, together with scientists from Mayo Clinic’s Florida campus and Johns Hopkins School of Medicine, has been awarded $7.2 million from the National Institute of Neurological Disorders and Stroke of The National Institutes of Health to create new RNA-based treatments for the most common form of amyotrophic lateral sclerosis (ALS), as well as a type of frontotemporal dementia (FTD).

http://ift.tt/2ttR3SV